Adam Taich

Adam S. Taich has served as our Chief Financial Officer since August 2024.

Prior to 10x Genomics, Adam was Chief Strategy Officer of Standard BioTools Inc. from January 2024 to July 2024. He previously served as interim Chief Executive Officer of SomaLogic, Inc., a proteomics company, from March 2023 until SomaLogic’s acquisition by Standard BioTools in January 2024. Adam joined SomaLogic as Chief Business Officer in November 2021 and later took on expanded responsibilities as SomaLogic’s Executive Vice President of Life Sciences.

Prior to joining SomaLogic, Adam spent 19 years at ThermoFisher Scientific, a global supplier of scientific instrumentation, reagents and software services. He held various roles including as Vice President & General Manager—Molecular Biology; Vice President—Strategy and Business Development; Vice President & General Manager—Protein and Cell Analysis and Vice President & General Manager—Global Services and Support.

Adam holds a bachelor’s degree in Political Science and Russian from Miami University in Oxford, Ohio.